Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C027132 |
1-anilino-8-naphthalenesulfonate |
1-anilino-8-naphthalenesulfonate binds to PAEP protein | affects binding | 16461020
|
C057349 |
2,4-decadienal |
2,4-decadienal affects the metabolism of PAEP protein | affects metabolic processing | 17226935
|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal affects the metabolism of PAEP protein | affects metabolic processing | 17226935
|
C403894 |
4-oxo-2-nonenal |
4-oxo-2-nonenal affects the metabolism of PAEP protein | affects metabolic processing | 17226935
|
D000171 |
Acrolein |
Acrolein affects the metabolism of PAEP protein | affects metabolic processing | 17226935
|
D002330 |
Carmustine |
Carmustine results in decreased expression of PAEP mRNA | decreases expression | 15980968
|
D004958 |
Estradiol |
PAEP protein modified form results in increased metabolism of Estradiol | increases metabolic processing | 17649829
|
D004958 |
Estradiol |
PAEP protein results in increased secretion of Estradiol | increases secretion | 17649829
|
D004967 |
Estrogens |
PAEP protein modified form results in increased abundance of Estrogens | increases abundance | 15852231
|
D004967 |
Estrogens |
PAEP protein results in increased abundance of Estrogens | increases abundance | 15852231
|
D019791 |
Guanidine |
Guanidine results in decreased stability of PAEP protein modified form | decreases stability | 12755705
|
D019791 |
Guanidine |
Trehalose inhibits the reaction [Guanidine results in decreased stability of PAEP protein modified form] | decreases reaction|decreases stability | 12755705
|
D006854 |
Hydrocortisone |
PAEP protein modified form results in increased metabolism of Hydrocortisone | increases metabolic processing | 17649829
|
D008315 |
Malondialdehyde |
Malondialdehyde affects the metabolism of PAEP protein | affects metabolic processing | 17226935
|
D017258 |
Medroxyprogesterone Acetate |
Medroxyprogesterone Acetate promotes the reaction [trichostatin A results in increased expression of PAEP mRNA] | increases expression|increases reaction | 17339403
|
D017258 |
Medroxyprogesterone Acetate |
Medroxyprogesterone Acetate results in increased expression of PAEP mRNA | increases expression | 17339403
|
D010165 |
Palladium |
Palladium binds to PAEP protein | affects binding | 17097727
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid binds to and results in decreased folding of PAEP protein | affects binding|decreases folding | 16019014
|
D011374 |
Progesterone |
PAEP protein modified form results in increased abundance of Progesterone | increases abundance | 15852231
|
D011374 |
Progesterone |
PAEP protein modified form results in increased metabolism of Progesterone | increases metabolic processing | 17649829
|
D011374 |
Progesterone |
PAEP protein results in increased abundance of Progesterone | increases abundance | 15852231
|
D011374 |
Progesterone |
Progesterone results in decreased expression of PAEP | decreases expression | 17510236
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PAEP mRNA | increases expression | 15886252
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PAEP protein | increases expression | 15886252
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased secretion of PAEP protein | increases secretion | 15886252
|
D014199 |
Trehalose |
Trehalose inhibits the reaction [Guanidine results in decreased stability of PAEP protein modified form] | decreases reaction|decreases stability | 12755705
|
D014199 |
Trehalose |
Trehalose results in increased stability of PAEP protein modified form | increases stability | 12755705
|
C012589 |
trichostatin A |
Medroxyprogesterone Acetate promotes the reaction [trichostatin A results in increased expression of PAEP mRNA] | increases expression|increases reaction | 17339403
|
C012589 |
trichostatin A |
trichostatin A results in increased expression of PAEP mRNA | increases expression | 17339403
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.81 | 14514962 15322242 11752688 |
MESH:D055371 |
Acute Lung Injury |
|
Acrolein |
4.67 | 20525806 21297076 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.09 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.34 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
Acrolein |
3.26 | 17570602 15207723 14715435 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
4.07 | 10965797 |
MESH:D000740 |
Anemia |
|
Malondialdehyde |
9.23 | 17278206 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
9.23 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Acrolein |
4.97 | 15014928 |
MESH:D050197 |
Atherosclerosis |
|
Acrolein |
3.95 | 16037261 16126721 17363696 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.00 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.76 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.73 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.31 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.22 | 15665606 15845082 15380490 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
4.35 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.84 | 17261762 14630087 19861407 17018787 16675129 12948864 17289903 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.84 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.84 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.43 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.76 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
3.48 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estrogens |
3.48 | 15341023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.34 | 18850075 16120746 18670907 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.74 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.12 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Hydrocortisone |
6.25 | 15826874 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
6.25 | 15668235 12621046 16354765 15340226 8697196 |
MESH:D015179 |
Colorectal Neoplasms |
|
Acrolein |
2.92 | 17597105 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.02 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Hydrocortisone |
2.98 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 10048152 15322242 20055451 |
MESH:D016638 |
Critical Illness |
|
Estrogens |
5.91 | 16670151 |
MESH:D003556 |
Cystitis |
|
Acrolein |
5.36 | 12161096 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.66 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.37 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.45 | 17187935 |
MESH:D003967 |
Diarrhea |
|
Hydrocortisone |
4.68 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.52 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.73 | 11462148 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
6.81 | 17259670 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.81 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.87 | 16714409 18230668 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.74 | 17692515 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
5.61 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.95 | 11473722 18566989 19148513 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.80 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.80 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 11564622 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.42 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.91 | 20067830 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
7.66 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
7.66 | 18801729 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.57 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.31 | 10048152 11294989 |
MESH:D016481 |
Helicobacter Infections |
|
Malondialdehyde |
5.93 | 17278206 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.29 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
8.54 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.54 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.00 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.72 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.02 | 8697196 15340226 16959395 16354765 18606429 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
3.81 | 12083418 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.89 | 18850075 18670907 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.36 | 15869954 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
8.26 | 12083418 |
MESH:D007249 |
Inflammation |
|
Progesterone |
8.26 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.26 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.94 | 16627594 16393666 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.29 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Acrolein |
6.40 | 12488133 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.40 | 15618244 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Malondialdehyde |
5.82 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
2.94 | 15610895 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Palladium |
6.47 | 17097727 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
2.90 | 18206229 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.19 | 8812269 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
2.24 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.24 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
4.60 | 18709148 14757943 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.60 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.08 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Acrolein |
4.18 | 11504702 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.23 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.96 | 17203775 11408345 16891317 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
5.96 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.45 | 19453300 |
MESH:D008545 |
Melanoma |
|
Carmustine |
3.93 | 12393984 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
3.93 | 16505122 |
MESH:D008546 |
Melanoma, Experimental |
|
Acrolein |
5.17 | 10803710 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
3.84 | 18172295 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.98 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.24 | 16810080 |
MESH:D009369 |
Neoplasms |
|
Acrolein |
3.52 | 17329238 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.70 | 17289903 |
MESH:D009393 |
Nephritis |
|
Acrolein |
6.26 | 12653641 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.33 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.33 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acrolein |
4.47 | 11342003 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.91 | 9802331 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
11.30 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Medroxyprogesterone Acetate |
11.30 | 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
11.30 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
11.30 | 19331143 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
3.27 | 19294695 |
MESH:D010300 |
Parkinson Disease |
|
Acrolein |
3.57 | 17690948 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.22 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
13.37 | 11550810 |
MESH:D010787 |
Photosensitivity Disorders |
|
Acrolein |
13.37 | 11550810 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.52 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
9.55 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.55 | 11222880 11118676 11399792 11896295 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
5.21 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.84 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.52 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
3.52 | 19789329 18798265 |
MESH:D051437 |
Renal Insufficiency |
|
Acrolein |
4.97 | 12732208 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.80 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.84 | 18045962 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.02 | 16192470 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.24 | 15862959 16503802 |
MESH:D020521 |
Stroke |
|
Acrolein |
4.52 | 16269634 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.87 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.66 | 19048282 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.57 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.22 | 15886252 |
MESH:D014947 |
Wounds and Injuries |
|
Estrogens |
4.70 | 11172683 |